
Is BSX (Boston Scientific Corporation) Halal or Haram?
Boston Scientific Corporation comfortably passes all AAOIFI Shariah screens, making it a Halal investment option. The company maintains an impressively low debt-to-market cap ratio of 13.7%, well below the 33% threshold. Furthermore, its interest income represents 0.00% of revenue, demonstrating a clean, operationally focused balance sheet devoid of impermissible financial gains.
Price Chart (5D)
BSX — Last 7 Days
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| 2026-05-01 | 57.93 | 58.17 | 56.50 | 56.50 | 18.3M | -2.47% |
| 2026-04-30 | 57.08 | 57.90 | 56.05 | 57.61 | 21.7M | +0.93% |
| 2026-04-29 | 57.71 | 57.83 | 56.17 | 57.15 | 20.7M | -0.97% |
| 2026-04-28 | 60.21 | 60.52 | 58.02 | 58.45 | 16.9M | -2.92% |
| 2026-04-27 | 61.21 | 61.73 | 59.93 | 59.95 | 17.6M | -2.06% |
| 2026-04-24 | 65.80 | 65.97 | 61.96 | 62.07 | 17.7M | -5.67% |
| 2026-04-23 | 65.57 | 66.88 | 64.93 | 65.69 | 31.3M | +0.18% |
Discussion
Sign in to join the discussion
Loading comments...
Shariah Screening Details for BSX
Business Activity
Permissible
Boston Scientific's business activity is permissible because developing and manufacturing life-saving medical devices like pacemakers and defibrillators inherently aligns with Islamic principles of preserving human life.
Debt / Market Cap
13.70%
Interest Income
0.00%
Cash & Securities
2.26%
About Boston Scientific Corporation (BSX)
Boston Scientific Corporation is a global leader in the healthcare sector, specializing in the development and manufacturing of innovative medical devices. Its core product portfolio includes life-saving technologies such as pacemakers, implantable defibrillators, and devices used to diagnose and treat gastrointestinal, pulmonary, and urological conditions.
For Muslim investors, BSX represents a solid Halal investment opportunity, having successfully passed all four AAOIFI Shariah screens. The company's core business of medical technology is highly encouraged in Islam, and its clean financial structure means investors can confidently add this stock to their halal portfolios without compromising their faith.
From an Islamic finance perspective, Boston Scientific's financial health is robust and compliant. The company operates with a conservative debt-to-market capitalization ratio of 13.7% and holds just 2.3% in cash and interest-bearing securities, keeping it well within permissible limits while generating zero impermissible interest income.
Since there is no significant scholarly debate regarding the permissibility of life-saving medical devices, the primary focus for Islamic investors should be ongoing monitoring. Investors should periodically review the company's debt levels and cash reserves during future earnings reports to ensure continued compliance with AAOIFI thresholds.
CEO
Michael F. Mahoney
Employees
53,000
IPO Date
1992-05-19
Headquarters
Marlborough, MA, US
Website
www.bostonscientific.comBSX Key Financial Statistics
Revenue
$20.07B
Net Income
$2.89B
EPS (Diluted)
$1.94
Stock Price
60.97
Beta
0.78
52-Week Range
59.39-109.5
Total Debt
$12.42B
Total Equity
$24.23B
Current Ratio
1.62
BSX Financial Health & Profitability
Profit Margins
Revenue Growth (YoY)
+19.9%
Prior year: $16.75B
Net Debt
$10.37B
Cash: $2.04B — Debt: $12.42B
R&D Spending
$2.05B
% of Revenue
10.2%
Frequently Asked Questions About BSX
Is BSX (Boston Scientific Corporation) stock halal to invest in?▾
What does Boston Scientific Corporation do?▾
What screening criteria were used for BSX?▾
Does BSX require income purification?▾
When was BSX last screened?▾
Disclaimer
This shariah compliance assessment for BSX (Boston Scientific Corporation) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-27.